The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction
Maha Mohammad Elsabaawy, Shimaa Rashad Abdelhamid, Ayman Alsebaey, Eman Abdelsamee, Manar Abdelaal Obada, Tary Abdelhamid Salman, Eman Rewisha
Clin Mol Hepatol. 2015;21(4):365-371.   Published online 2015 Dec 24     DOI:
Citations to this article as recorded by Crossref logo
Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial
Hyung Joon Yim, Tae Hyung Kim, Sang Jun Suh, Sun Young Yim, Young Kul Jung, Yeon Seok Seo, Seong Hee Kang, Moon Young Kim, Soon Koo Baik, Hong Soo Kim, Young Seok Kim, Soo Young Park, Byung Ik Kim, Jun Yong Park, Jeong Heo, Joo Hyun Sohn, Nae-Yun Heo, Kwa
American Journal of Gastroenterology.2023; 118(4): 654.     CrossRef
Use of laparocentesis in the treatment of ascites in patients with liver cirrhosis
E. V. Mahiliavets, Y. N. Bozhko, O. N. Mahiliavets
Proceedings of the National Academy of Sciences of Belarus, Medical series.2021; 18(3): 362.     CrossRef
Concordance of 24- and 48-h diagnostic follow-up ascitic fluid polymorphonuclear leukocyte count in the guidance of the antibiotic therapy in spontaneous bacterial peritonitis
Hanaa Mostafa Badran, Maha Mohammad Elsabaawy, Mohamed Azazy Mahmoud, Heba Samy Ghanem, Ayman Alsebaey, Warda Othman
Egyptian Liver Journal.2021;[Epub]     CrossRef
Clinical Progress Note: Intravenous Human Albumin in Patients With Cirrhosis
Suchita Shah Sata, Omobonike Oloruntoba Sanders, Catherine A Curley
Journal of Hospital Medicine.2021; 16(12): 738.     CrossRef
Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review
Anand V Kulkarni, Pramod Kumar, Mithun Sharma, T R Sowmya, Rupjyoti Talukdar, Padaki Nagaraj Rao, D Nageshwar Reddy
Journal of Clinical and Translational Hepatology.2020; 8(X): 1.     CrossRef
High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction
Ayman Alsebaey, Eman Rewisha, Imam Waked
Egyptian Liver Journal.2020;[Epub]     CrossRef
Paracentesis-induced circulatory dysfunction: are there albumin alternatives?
Ayman Alsebaey, Eman Rewisha, Imam Waked
Egyptian Liver Journal.2020;[Epub]     CrossRef
Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study
Tae Hyung Kim, Yeon Seok Seo, Seong Hee Kang, Moon Young Kim, Sang Gyune Kim, Hyo Young Lee, Jeong‐Hoon Lee, Young‐Sun Lee, Ji Hoon Kim, Soung Won Jeong, Jae Young Jang, Ki Tae Suk, Young Kul Jung, Hyonggin An, Hyung Joon Yim, Young Seok Kim, Soon Ho Um
Liver International.2020; 40(12): 3083.     CrossRef
Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N‐acetyl‐β‐D‐glucosaminidase
Tae Hyung Kim, Han Ah Lee, Yeon Seok Seo, Yoo Ra Lee, Sun Young Yim, Young Sun Lee, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Journal of Gastroenterology and Hepatology.2019; 34(1): 234.     CrossRef
Current approaches to the management of patients with cirrhotic ascites
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev
World Journal of Gastroenterology.2019; 25(28): 3738.     CrossRef
Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective
J.F. Crismale, K.A. Meliambro, S. DeMaria, D.B. Bronster, S. Florman, T.D. Schiano
American Journal of Transplantation.2017; 17(10): 2537.     CrossRef
What we know about paracentesis induced circulatory dysfunction?
Jeong Han Kim
Clinical and Molecular Hepatology.2015; 21(4): 349.     CrossRef